EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Bone Disease in Multiple Myeloma: Pathophysiology and Management

Abdul Hameed, Jennifer J Brady, Paul Dowling, Martin Clynes, Peter O'Gorman

Cancer Growth and Metastasis · 2014

DOI: 10.4137/cgm.s16817 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Growth and Metastasis, 2014. Verfasst von Abdul Hameed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan. ; Mater Misericordaie University Hospital…. Die Arbeit wurde bisher 139-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM). More than 80% of MM patients suffer from destructive bony lesions, leading to pain, fractures, mobility issues, and neurological deficits. MBD is not only a main cause of disability and morbidity in MM patients but also increases the cost of management. Bone destruction and lack of bone formation are main factors in the development of MBD. Some novel factors are found to be involved in the pathogenesis of MBD, eg, receptor activator of nuclear factor kappa-B ligand (RANKL), osteoprotegerin (OPG) system (RANKL/OPG), Wingless (Wnt), dickkopf-1 (Wnt/DKK1) pathway. The addition of novel agents in the treatment of MM, use of bisphosphonates and other supportive modalities such as radiotherapy, vertebroplasty/kyphoplasty, and surgical interventions, all have significant roles in the treatment of MBD. This review provides an overview on the pathophysiology and management of MBD.

Schlagwörter

Stichwörter der Autor:innen

bisphosphonatescytokinesosteoblastogenesisosteoblastsosteoclastogenesisosteoclasts

Autor:innen und Institutionen

  • Medical Oncology Department, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan. ; Mater Misericordaie University Hospital, Dublin, Ireland. ; Dublin City University, Dublin, Ireland.
  • Department of Biochemistry, Mater Misericordaie University Hospital, Dublin, Ireland.
  • National Institute for cellular Biotechnology, Dublin City University, Dublin, Ireland.
  • National Institute for cellular Biotechnology, Dublin City University, Dublin, Ireland. ; Hematology Department, Mater Misericordaie University Hospital, Dublin, Ireland.

Zitieren

APA

Hameed, A., Brady, J. J., Dowling, P., Clynes, M., & O'Gorman, P. (2014). Bone Disease in Multiple Myeloma: Pathophysiology and Management. Cancer Growth and Metastasis. https://doi.org/10.4137/cgm.s16817

Vancouver

Hameed A, Brady JJ, Dowling P, Clynes M, O'Gorman P. Bone Disease in Multiple Myeloma: Pathophysiology and Management. Cancer Growth and Metastasis. 2014. doi:10.4137/cgm.s16817

BibTeX
@article{Hameed2014,
  author = {Hameed, Abdul and Brady, Jennifer J and Dowling, Paul and Clynes, Martin and O'Gorman, Peter},
  title = {Bone Disease in Multiple Myeloma: Pathophysiology and Management},
  journal = {Cancer Growth and Metastasis},
  year = {2014},
  doi = {10.4137/cgm.s16817}
}
Kostenlos starten →